WallStSmart
COCP

Cocrystal Pharma Inc

NASDAQ: COCP · HEALTHCARE · BIOTECHNOLOGY

$1.31
-8.16% today

Updated 2026-06-05

Market cap
$14.20M
P/E ratio
P/S ratio
64.95x
EPS (TTM)
$-0.72
Dividend yield
52W range
$1 – $2
Volume
3.0M

Cocrystal Pharma Inc (COCP) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
-1,047.00%
ROE
-214.50%
ROA
-62.40%
Debt/equity
0.35x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2007$-58723.00
2008$-52917.00
2009$-41370.00
2010$-48478.00
2011$12.61M$-5.46M31.46%-30.84%-43.29%
2012$17.19M$-7.96M42.01%-15.34%-46.33%
2013$-19.62M
2014$9000.00$-99000.0054.77%-64,433.33%-1,100.00%
2015$78000.00$-50.12M-146.15%-69,164.10%-64,258.97%
2016$0.00$-74.87M
2017$0.00$-613000.00
2018$0.00$-49.05M
2019$6.56M$-48.17M39.00%-737.45%-733.84%
2020$2.01M$-9.65M-199.60%-475.97%-479.05%
2021$5.43M$-14.19M-162.04%-262.04%-261.38%
2022$0.00$-38.84M
2023$0.00$-17.98M
2024$0.00$-17.50M
2025$0.00$-8.83M

Frequently asked questions

What is Cocrystal Pharma Inc's revenue?

Cocrystal Pharma Inc's trailing twelve-month revenue is $225000.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How much free cash flow does COCP generate?

COCP produced $-8.20M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is COCP's balance sheet healthy?

COCP holds $7.03M in cash and equivalents against — in long-term debt, on $6.33M of shareholder equity. That debt is best read against the cash flow the business throws off each year.